Advertisement

Advertisement

34th Annual EAU Congress

prostate cancer

By The ASCO Post Staff / 34th Annual EAU Congress

EAU 2019: Testosterone Replacement Therapy May Slow Recurrence in Low-Risk Prostate Cancer

Researchers have shown that testosterone replacement may slow the recurrence of prostate cancer in low-risk patients. Findings from the study were presented by Towe et al at the European Association o...

By The ASCO Post Staff / 34th Annual EAU Congress

EAU 2019: Early Menopause in Smokers May Be Linked to Increased Risk of Bladder Cancer

New research has shown that experiencing menopause before the age of 45 is associated with a higher risk of bladder cancer; this higher risk was even more notable in smokers. The study, which looked a...

Advertisement

Advertisement

Dec

23

Today In Oncology

Study Finds Daratumumab Monotherapy Prevented or Delayed Progression From Smoldering to Active Multiple Myeloma

Study Finds Genetic Changes, Elevated Leukemia Risk in Ground Zero First Responders

MRI First Strategy May Be Safe for Prostate Cancer Detection

Addition of SBRT to Systemic Therapy May Improve Outcomes in Select Patients With Locally Advanced Hepatocellular Carcinoma

Epcoritamab Monotherapy for Pretreated Relapsed or Refractory CLL

Advertisement

© 2024 HSP News Service, L.L.C.